Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02098967 |
| Title | A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia. |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Hoffmann-La Roche |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Colorado | Aurora | Colorado | 80045 | United States | Details | |
| Washington University | Saint Louis | Missouri | 63110 | United States | Details | |
| Medical University of South Carolina; Hollings Cancer Center | Charleston | South Carolina | 29425 | United States | Details | |
| University Health Network; Princess Margaret Hospital; Medical Oncology Dept | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Jewish General Hospital / McGill University | Montreal | Quebec | H3T 1E2 | Canada | Details |